Giulio Settanni
Verona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Exploring alternatives to tumor tissue for BRCA1/2 next-generation sequencing testing in high-grade serous ovarian cancer: A 34-case series of malignant ascites.
Journal: Cancer cytopathology
Published: January 21, 2026
Prevalence of CDKN2A, CDK4, POT1, BAP1, MITF, ATM, and TERT Pathogenic Variants in a Single-Center Retrospective Series of Patients With Melanoma and Personal or Family History Suggestive of Genetic Predisposition.
Journal: Dermatology practical & conceptual
Published: February 01, 2024
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy.
Journal: Virchows Archiv : an international journal of pathology
Published: September 19, 2023
First-line tepotinib for a very elderly patient with metastatic NSCLC harboring MET exon 14 skipping mutation and high PD-L1 expression.
Journal: Drug target insights
Published: July 03, 2023
Niraparib for the Treatment of Metastatic NSCLC in a Patient With BRCA2 Germinal Mutation: A Case Report.
Journal: Clinical lung cancer
Published: June 17, 2023
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 14, 2021
A Multi-Center, Real-Life Experience on Liquid Biopsy Practice for EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) Patients.
Journal: Diagnostics (Basel, Switzerland)
Published: September 08, 2020
Toward the molecular dissection of peritoneal pseudomyxoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 11, 2016
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.
Journal: Journal of translational medicine
Published: December 16, 2015
G48A, a New KRAS Mutation Found in Lung Adenocarcinoma.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 12, 2015
AKT1 and BRAF mutations in pediatric aggressive fibromatosis.
Journal: Cancer medicine
Published: October 06, 2015
Last Updated: 09/26/2026